<乌鸦传媒>Chemo-Free Regimen Boosts OS in Mesothelioma Big advantage for nivolumab-ipilimumab in nonepithelioid tumors drives advantage over chemo Aug 09, 2020
<乌鸦传媒>Another ALK Drug Tops Crizotinib in First-Line NSCLC Ensartinib doubled PFS over older standard, with improved CNS activity Aug 08, 2020
<乌鸦传媒>COVID-19 More Deadly Than Cancer Itself? Highlights from the AACR conference on COVID-19 and cancer Jul 24, 2020
<乌鸦传媒>The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<乌鸦传媒>Cancer Immunotherapy Tied to Severe COVID-19 Outcomes Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<乌鸦传媒>Paradigm Shift Coming for Early NSCLC? Postoperative osimertinib doubles DFS in patients with stages Ib-IIIa EGFR+ lung cancer May 28, 2020
<乌鸦传媒>End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News' News, features, and commentary about cancer-related issues May 28, 2020
<乌鸦传媒>6-Week Keytruda Safe, Effective in Melanoma Schedule gets FDA approval for all adult indications Apr 30, 2020
<乌鸦传媒>COVID-19 Mortality Spikes in Patients With Lung, Blood Cancers Those with metastatic disease also at special risk for poor outcomes Apr 28, 2020
<乌鸦传媒>How Prevalent Is Checkpoint Inhibitor Thyroid Dysfunction, Really? Real-world data offer word of caution for oncologists Apr 01, 2020
<乌鸦传媒>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<乌鸦传媒>No DNA Damage Seen With Single Low-Dose CT Scan Some reassurance for annual lung cancer screening safety Mar 10, 2020
<乌鸦传媒>Rush Limbaugh's Advanced Lung Cancer Conservative talk show host announces diagnosis Feb 13, 2020
<乌鸦传媒>PD-1 vs PD-L1 Inhibitors: Do Outcomes Differ? Meta-analysis suggests they aren't equivalent Dec 27, 2019
<乌鸦传媒>Pembrolizumab Shows Survival Benefit in KRAS-Mutant NSCLC Improved OS, PFS, and response rates compared to chemo in first-line Dec 16, 2019
<乌鸦传媒>AHA Dedicates $20 Million to Youth Vaping Research Association and partners aim to "hold e-cigarette companies publicly accountable for their lies" Nov 16, 2019
<乌鸦传媒>Rheumatoid Arthritis Is No Bar to Cancer Immunotherapy Small study finds flares common with checkpoint inhibitors, but few patients stopped treatment because of them Nov 13, 2019
<乌鸦传媒>Abnormal Shadow on Chest Radiograph Culture findings were key in making the diagnosis Nov 11, 2019
<乌鸦传媒>Notable OS Gains with Dual Immunotherapy in Advanced NSCLC Secondary analysis of CheckMate 227 brings more good news for nivolumab-ipilimumab combo Sep 28, 2019
<乌鸦传媒>BCG Vax: A Shot Against Lung Cancer in Native Populations? 60-year follow-up data from a vaccine trial found surprising results Sep 25, 2019
<乌鸦传媒>Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLC Increased systemic response rate, disease control rate, and PFS in phase II trial Sep 17, 2019
<乌鸦传媒>Anti-PD-1/L1 for NSCLC Sparks Talk of the 'C' Word Unprecedented survival at 3 and 5 years, but investigators reluctant to say "cure" Sep 10, 2019
<乌鸦传媒>'Dirtier' Drugs Step Aside in RET-Positive NSCLC Over two-thirds of patients respond to selective RET inhibitor Sep 09, 2019
<乌鸦传媒>TMB in Lung Cancer: 'Not Ready for Prime Time' No association between tumor mutational burden and outcomes in three trials Sep 09, 2019
<乌鸦传媒>Small Cancer Risk With Lung Micronodules Supports classifying small nodules as negative scan result Jul 10, 2019
<乌鸦传媒>More Clarity to Steroids' Effect on Anti-PD-1 Therapy Adverse effects driven by palliative indications associated with poor prognosis Jun 27, 2019
<乌鸦传媒>Rheumatologist's Primer on Checkpoint Inhibitors Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<乌鸦传媒>Durable Responses With Keytruda in Later-Line SCLC Plus umbralisib in marginal zone lymphoma and a next-generation TRK-targeted agent Apr 04, 2019
<乌鸦传媒>MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC Savolitinib promising in patients with MET-based resistance to EGFR inhibition Apr 01, 2019 video
<乌鸦传媒>CAR T-Cell Therapy Active in Solid Tumors Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
<乌鸦传媒>Aggressive Tx in Oligometastatic NSCLC Tied to Improved OS Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
<乌鸦传媒>Liquid Biopsy Matches Tissue for NSCLC Guidance Increased mutation detection rate, faster turnaround time Feb 27, 2019
<乌鸦传媒>Rapid Heart Rate Tied to Higher Mortality in Cancer Patients Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<乌鸦传媒>Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<乌鸦传媒>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<乌鸦传媒>Immunotherapy Combo Flops in Metastatic NSCLC Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
<乌鸦传媒>Highlights from Molecular Targets Symposiuim Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<乌鸦传媒>Group of Blood Pressure Drugs Linked to Lung Cancer 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018
